Sfoglia per Autore
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas.
2000-01-01 M. NOVELLI; SAVOIA P; CAMBIERI I; PONTI R; COMESSATTI A; LISA F; BERNENGO MG
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern
2001-01-01 P. QUAGLINO; S. OSELLA-ABATE; M. NOVELLI; F. LISA; A. COMESSATTI; M.G. BERNENGO
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course.
2002-01-01 OSELLA-ABATE S ;QUAGLINO P ;SAVOIA P ;LEPORATI C ;COMESSATTI A ;BERNENGO MG
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients.
2003-01-01 Novelli M; Comessatti A;Quaglino P;Savoia P; Fierro MT; Bernengo MG.
Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report
2005-01-01 SAVOIA P; QUAGLINO P; OSELLA-ABATE S; COMESSATTI A; NARDÒ T; BERNENGO MG
T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings
2005-01-01 PONTI R; QUAGLINO P; NOVELLI M; FIERRO MT; COMESSATTI A; PERONI A; BONELLO L; BERNENGO M (PR e QP equal contribution)
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients.
2006-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.
2007-01-01 BERNENGO MG; QUAGLINO P; COMESSATTI A; ORTONCELLI M; NOVELLI M; LISA F; FIERRO MT
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients.
2008-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Lisa F; Fierro MT
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status
2008-01-01 SAVOIA P; OSELLA ABATE S; COMESSATTI A; NARDO T; MARCHIO C; PACCHIONI D; QUAGLINO P; BERNENGO MG
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role
2008-01-01 Ponti R.; Bergallo M.; Costa C.; Quaglino P.; Fierro M.T.; Comessatti A.; Sidoti F.; Merlino C.; Novelli M.; Alotto D.; Cavallo R.; Bernengo M.G.
Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme
2008-01-01 QUAGLINO P; CAPRONI M; OSELLA-ABATE S; TORCHIA D; COMESSATTI A; DEL BIANCO E; ANTIGA E; FREZZOLINI A; SCHENA D; MARZANO A; DE SIMONE C; PARODI A; FABBRI P; BERNENGO MG
TCRgamma-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples
2008-01-01 PONTI R; FIERRO MT; QUAGLINO P.; BONELLO L; FRANCIA DI CELLE P; ORTONCELLI M; FAVA P; COMESSATTI A; NOVELLI M; BERNENGO MG
Flow cytometry immunophenotyping in mycosis fungoides
2008-01-01 Novelli M; Fierro MT; Quaglino P; Comessatti A; Lisa F; Ponti R; Savoia P; Bernengo MG.
Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma
2008-01-01 M.T. FIERRO; M. NOVELLI; P. QUAGLINO; A. COMESSATTI; P. FAVA; M. ORTONCELLI; R. PONTI; M.G. BERNENGO
Phenotypical and functional alterations of polymorphonucleates in sezary syndrome patients
2009-01-01 M. Novelli; P. Quaglino; C. Merlino; G. Banche; M.T. Fierro; A. Comessatti; R. Ponti; A Cuffini; M.G. Bernengo
Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects
2009-01-01 Sidoti F; Fierro MT; Costa C; Ponti R; Bergallo M; Comessatti A; Fumagalli M; Novelli M; Merlino C; Cavallo R; Bernengo MG.
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
2009-01-01 Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG.
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood
2009-01-01 Novelli M; Merlino C; Ponti R; Bergallo M; Quaglino P; Cambieri I; Comessatti A; Sidoti F; Costa C; Corino D; Cavallo R; Ponzi AN; Fierro MT; Bernengo MG.
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients.
2009-01-01 Quaglino P; Ortoncelli M; Comessatti A; Ponti R; Novelli M; Bergallo M; Costa C; Cicchelli S; Savoia P; Bernengo MG.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile